cover image - Brody's Human Pharmacology Elsevier eBook on VitalSource, 6th Edition
ISBN: 9780323596640
Copyright: 2019
Publication Date: 06-06-2018
Page Count: 712
Imprint: Elsevier
List Price: $67.99

Brody's Human Pharmacology Elsevier eBook on VitalSource, 6th Edition

by Lynn Wecker, PhD

Elsevier eBook on VitalSource

cover image - Brody's Human Pharmacology Elsevier eBook on VitalSource, 6th Edition
ISBN: 9780323596640
Copyright: 2019
Publication Date: 06-06-2018
Page Count: 712
Imprint: Elsevier
List Price: $67.99
Was $67.99

Now $61.19

Or $0.00 with a valid access code

Focusing on the essential aspects of pharmacology you need to know, Brody's Human Pharmacology: Mechanism-Based Therapeutics, 6th Edition, keeps you fully up to date with all that’s new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information.

    • NEW chapter devoted entirely to pharmacogenomics and personalized medicine
    • NEW chapter on cannabinoids and their use for pain and other disorders, in light of recent legalization in many states
    • NEW chapters on recent developments in the treatment of Alzheimer's disease, ADHD and the latest treatments for HIV
    • NEW section on pain management
    • NEW section in each chapter covering "Clinical Relevance for Healthcare Professionals" that provides important information specific to physical therapists, dentists and dental hygienists, and many other medical professionals

    Plus these student-friendly features:

    • A new organizational approach, focusing on integration and systems-based learning
    • Contributions from leading faculty who cover the most important aspects of pharmacology necessary for a basic understanding of the subject, including concepts, clinical applications, and side effects
    • USMLE-style self-assessment questions at the end of every chapter, answers and rationales in the Appendix
    • Online access to Student Consult―where you’ll find the complete contents of the book, fully searchable, 150 USMLE-style questions, and more

  • Section 1: Mechanisms of Drug Action and Therapeutic Principles

    1. Introduction, Terminology
    2. Pharmacodynamics: Drug Targets (Receptors, Enzymes, DNA, etc)
    3. Pharmacokinetics
    4. Pharmacogenomics
    5. Drug Discovery, Development, and Regulation

    Section 2: Chemical Mediators and Drugs Affecting Autonomic and Neuromuscular Synapses
    6. Introduction to the Peripheral Nervous Systems and Drugs for Peripheral Disorders

    Cholinergic Drugs
    7. Muscarinic Agonists and Their Clinical Uses
    8. Muscarinic Antagonists and Their Clinical Uses
    9. Nicotinic Agonists and Their Clinical Uses
    10. Nicotinic Antagonists and Neuromuscular Blocking Drugs

    Adrenergic Drugs
    11. Adrenergic Agonists and Their Clinical Uses
    12. Adrenergic Antagonists and Their Clinical Uses

    Section 3: Drug Treatment for Disorders Affecting the Central Nervous System
    13. Introduction to the CNS and Drugs Affecting the Brain

    Neurodegenerative Disorders
    14. Drug Therapy for Alzheimer's Disease and Other Cognitive Disorders/Dementias
    15. Pharmacotherapy of Basal Ganglia Disorders: Parkinson's Disease and Huntington's Disease
    16. Drug Therapy for Psychoses and Bipolar Disorder
    17. Drug Therapy for Depression and Anxiety
    18. Drug Therapy for the Management of Attention Deficit Hyperactivity Disorder
    19. Drug Therapy for Insomnia and the Hypersomnias
    20. Drug Therapy for Managing Obesity and Eating Disorders
    21. Treatment of Seizure Disorders
    22. Drug Therapy to Control Spasticity Disorders
    23. Ethanol, Other Alcohols, and Drugs for Alcohol Use Disorder
    24. Illicit Psychoactive Compounds and Substance Use Disorder

    Section 4: Drug Therapy for Pain Management
    25. Introduction
    26. General Anesthetics
    27. Local Anesthetics
    28. Opioid Analgesics
    29. Nonsteroidal Anti-inflammatory Agents and Acetaminophen
    30. Cannabinoids

    Section 5: Treatment of Inflammatory, Allergic and Immunologic Disorders
    31. Drug Therapy for Migraine Headache
    32. Drug Therapy for Gout and Hyperuricemia
    33. Drug Treatment for Allergic Reactions
    34. Immunosuppressants for Autoimmune Disorders and Organ Transplantation
    35. Drug Therapy for Rheumatoid Arthritis

    Section 6: Drug Treatment for Cardiovascular Diseases
    36. Introduction to The Cardiovascular System and the Regulation of Blood Pressure and Heart Rate
    37. Overview of Hypertension Management and Drugs that Decrease Sympathetic Tone
    38. Diuretics and Drugs that Affect Volume and Electrolyte Content
    39. Drugs Affecting the Renin-Angiotensin-Aldosterone System
    40. Calcium Channel Blockers
    41. Vasodilators
    42. Drug Therapy for Hyperlipidemias and Atherosclerotic Cardiovascular Disease
    43. Drug Therapy for Myocardial Ischemia and Angina Pectoris
    44. Treatment of Heart Failure: Cardiac Glycosides, Phosphodiesterase Inhibitors and Other Agents
    45. Antiarrhythmic Drugs
    46. Anticoagulant, Antiplatelet and Thrombolytic Agents
    47. Drug Therapy for Hemophilia and the Anemias

    Section 7: Treatment of Endocrine Disorders
    48. Introduction to Endocrine Pharmacology
    49. Treatment of Hypothalamic and Pituitary Disorders
    50. Treatment of Adrenalcorticosteroid Disorders
    51. Female Hormone Regulation
    52. Androgens, antiandrogens and their clinical uses
    53. Drug Therapy for the Management of Diabetes
    54. Drug Therapy for the Management of Thyroid Disorders
    55. Calcium Regulating Hormones and Agents Affecting Bone

    Section 8: Chemotherapy

    Infectious Diseases
    56. Principles of Antimicrobial Use
    57. Bacterial Cell Wall Synthesis Inhibitors
    58. Inhibitors of Protein Synthesis
    59. Drugs that Target DNA
    60. Antimycobacterial Drugs and the Treatment of Tuberculosis and Leprosy
    61. Drug Therapy for Resistant Organisms

    Parasitic Diseases
    62. Antifungal Agents
    63. Antimalarial and Other Antiprotozoal Agents
    64. Antihelmintics

    Viruses
    65. Drug Therapy for non-HIV Viral Infections
    66. Drugs for HIV and Related Opportunistic Infections

    Cancer
    67. Introduction and Therapeutic Principles
    68. Cytotoxic Agents
    69. Targeted Agents

    Section 9: Special Considerations
    70. Therapeutic Use of Hematopoietic Growth Factors, Vitamins and Minerals
    71. Gastrointestinal Disorders and Their Treatment
    72. Pharmacological Treatment of Asthma and COPD
    73. The Role of Neutraceuticals and Natural Products
    74. Essentials of Toxicology
    75. Therapeutic Considerations for Pregnant, Pediatric, Geriatric and Obese Individuals

  • Lynn Wecker, PhD, Distinguished University Professor, Departments of Psychiatry and Behavioral Medicine and Molecular Pharmacology and Physiology, Director, Laboratory of Neuropsychopharmacology, USF College of Medicine, Tampa, Florida, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • No information about nonvisual reading is available
    • Conformance
      • No information is available
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $67.99

Now $61.19

Or $0.00 with a valid access code